Cutler Group LP Argenx Se Call Options Transaction History

Cutler Group LP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$356.95 - $413.29 $178,475 - $206,645	500 Added 100.0%	1,000 $6,000
Q4 2023 Jan 18, 2024	BUY	$338.91 - $506.01 $135,564 - $202,404	400 Added 400.0%	500 $0
Q3 2023 Nov 07, 2023	BUY	$369.35 - $548.43 $36,935 - $54,842	100 New	100 $11,000
Q2 2022 Aug 04, 2022	BUY	$269.58 - $378.88 $134,790 - $189,440	500 Added 50.0%	1,500 $46,000
Q4 2020 Jan 21, 2021	SELL	$248.13 - $308.36 $272,943 - $339,196	-1,100 Reduced 52.38%	1,000 $27,000
Q3 2020 Oct 27, 2020	SELL	$215.51 - $272.51 $1.81 Million - $2.29 Million	-8,400 Reduced 80.0%	2,100 $91,000
Q2 2020 Jul 22, 2020	BUY	$127.44 - $232.72 $458,784 - $837,792	3,600 Added 52.17%	10,500 $387,000
Q1 2020 May 07, 2020	BUY	$108.83 - $165.23 $21,766 - $33,046	200 Added 2.99%	6,900 $19,000
Q4 2019 Feb 06, 2020	BUY	$106.59 - $164.21 $671,517 - $1.03 Million	6,300 Added 1575.0%	6,700 $216,000
Q3 2019 Oct 28, 2019	SELL	$113.31 - $150.51 $294,606 - $391,326	-2,600 Reduced 86.67%	400 $0
Q2 2019 Aug 09, 2019	BUY	$115.0 - $141.58 $264,500 - $325,634	2,300 Added 328.57%	3,000 $58,000
Q4 2018 Feb 05, 2019	BUY	$63.81 - $109.82 $38,286 - $65,892	600 Added 600.0%	700 $1,000
Q3 2018 Nov 07, 2018	BUY	$75.5 - $96.63 $7,550 - $9,663	100 New	100 $0

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.